ZLAB vs LEGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
LEGN Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Legend Biotech Corporation American Depositary Shares (LEGN) driven by superior Valuation, Growth & Margin, Options & Structure while ZLAB counters with relative strength in Momentum & Technical. Fundamentally, ZLAB trades at N/M Forward P/E with -63.0% operating margin (-6.8% YoY revenue) versus LEGN at 27.5x Forward P/E and 2.8% operating margin (+32.0% YoY). In options structure, ZLAB sits in UNCLASSIFIED (58th %ile IV; Dealer Gamma Walls on Pro) against LEGN sits in UNCLASSIFIED (24th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ZLAB | LEGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.0B | $3.6B | Larger Scale | LEGN |
| Trailing P/E Ratio Valuation | N/M | 23.0x | Lower Multiple | LEGN |
| Forward P/E Ratio Valuation | N/M | 27.5x | Lower Multiple | LEGN |
| Revenue Growth (YoY) Growth | -6.8% | +32.0% | Higher Growth | LEGN |
| Operating Margin (TTM) Profitability | -63.0% | 2.8% | Higher Margin | LEGN |
| Net Profit Margin Profitability | -44.9% | -0.0% | Higher Margin | LEGN |
| Return on Equity (ROE) Capital Efficiency | -30.0% | -0.0% | Higher ROE | LEGN |
| 52-Week Range Position Momentum | 60% ($16โ$29) | 1% ($16โ$38) | Stronger Trend | ZLAB |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 78% Vol | 1.00ฮฒ ยท 82% Vol | Lower Realized Risk | ZLAB |
| Unified Institutional Score Composite Signal | 47.4 / 100 (HOLD) | 42.8 / 100 (HOLD) | Higher Composite | ZLAB |